FDA warns doctor not to promote ‘three-parent’ fertilization procedure

In a strongly worded August 4 letter, the FDA reminded New York-based Dr. John Zhang that it had declined his request to run clinical trials on the experimental technique mitochondrial replacement technology, or MRT and stop marketing an unapproved IVF technology that creates a human embryo using the DNA of three people.

Since December 2015, Congress has prohibited the FDA from reviewing applications on clinical tests involving genetically modified human embryos “until safety and ethical issues can be resolved,” reports Bloomberg BNA.  “Also, researchers don’t know what impact the procedure will have on the babies it produces,” it notes.

Click here for more from LifeSiteNews